Two previous cases of the development of Dupuytren’s contractures were reported in association with BRAF inhibitor treatment for BRAF V600E mutation-positive metastatic melanoma and metastatic papillary thyroid carcinoma. This evidence concerns the gene BRAF and metastatic melanoma.